Enlivex Therapeutics Ltd Cash Flow Reinvestment Rate

Latest as of March 2020: 2.62x

Enlivex Therapeutics Ltd cash flow reinvestment rate. Enlivex Therapeutics Ltd (ENLV) has a Cash Flow Reinvestment Rate of 2.62x as of March 2020, reinvesting ILA2.04 Million (capex ILA39.00K plus investments ILA-2.00 Million) from operating cash flow of ILA779.00K. Explore Enlivex Therapeutics Ltd (ENLV) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

2.62x

(Capex + Investments) / Operating CF

Total Reinvested

ILA2.04 Million

Capex + Investments

Operating Cash Flow

ILA779.00K

ILA

Capital Expenditures

ILA39.00K

ILA

Enlivex Therapeutics Ltd Cash Flow Reinvestment Rate by Year (None–None)

Enlivex Therapeutics Ltd cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Enlivex Therapeutics Ltd. For the full cash flow conversion analysis, see Enlivex Therapeutics Ltd operating cash flow efficiency.

Year	Reinvestment Rate	Total Reinvested (ILA)	Operating CF	Capex	YoY Change

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow